Trintellix and Luvox drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Trintellix (vortioxetine hydrobromide) and Luvox (fluvoxamine maleate). Common drug interactions include suicidal ideation among females and depressed mood among males.

The phase IV clinical study analyzes what interactions people have when they take Trintellix and Luvox. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Trintellix?

Trintellix has active ingredients of vortioxetine hydrobromide. It is often used in depression. eHealthMe is studying from 13,067 Trintellix users. Check the latest studies of Trintellix.

What is Luvox?

Luvox has active ingredients of fluvoxamine maleate. It is often used in obsessive-compulsive disorder. eHealthMe is studying from 13,439 Luvox users. Check the latest studies of Luvox.



On Jul, 20, 2026

25 people who take Trintellix and Luvox together, and have interactions are studied.

Trintellix and Luvox drug interactions.

What are the common drug interactions of Trintellix and Luvox, by gender? *:

female:

  1. Suicidal ideation
  2. Abdominal discomfort
  3. Agitation (state of anxiety or nervous excitement)
  4. Anger
  5. Blood pressure increased
  6. Mydriasis (a dilation of the pupil)
  7. Ocular discomfort (a generic expression when there is lack of ease in/about the eyes)
  8. Pyrexia (fever)
  9. Rash
  10. Tremor (trembling or shaking movements in one or more parts of your body)

male:

  1. Depressed mood
  2. Intentional self-injury
  3. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  4. Headache (pain in head)
  5. Hyperhidrosis (abnormally increased sweating)
  6. Nausea (feeling of having an urge to vomit)
  7. Tremor (trembling or shaking movements in one or more parts of your body)
  8. Suicide attempt
  9. Pruritus generalised (generalized itching)
  10. Benign prostatic hyperplasia (benign enlargement of the prostate)

What are the common drug interactions of Trintellix and Luvox, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Pruritus generalised (generalized itching)

20-29:

  1. Depressed mood
  2. Intentional self-injury
  3. Suicide attempt

30-39:

  1. Blood glucose increased
  2. Headache (pain in head)
  3. Hyperhidrosis (abnormally increased sweating)
  4. Nausea (feeling of having an urge to vomit)
  5. Tremor (trembling or shaking movements in one or more parts of your body)

40-49:

  1. Abdominal discomfort
  2. Agitation (state of anxiety or nervous excitement)
  3. Anger
  4. Blood pressure increased
  5. Mydriasis (a dilation of the pupil)
  6. Ocular discomfort (a generic expression when there is lack of ease in/about the eyes)
  7. Pyrexia (fever)
  8. Rash
  9. Suicidal ideation
  10. Tremor (trembling or shaking movements in one or more parts of your body)

50-59:

  1. Hypertension (high blood pressure)
  2. Obesity (having too much body fat)
  3. Therapeutic response unexpected
  4. Weight decreased
  5. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  6. Benign prostatic hyperplasia (benign enlargement of the prostate)

60+:

  1. Cardiomyopathy (weakening of the heart muscle)
  2. Constipation
  3. Dizziness
  4. Drug ineffective
  5. Nausea (feeling of having an urge to vomit)
  6. Arrhythmia (irregular heartbeat)
  7. Fall
  8. Myocarditis (inflammation of heart muscle myocardium)
  9. Upper limb fracture

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 28.00%
  2. Stress And Anxiety: 6 people, 24.00%
  3. Panic Disorder: 4 people, 16.00%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 16.00%
  5. Nausea (feeling of having an urge to vomit): 2 people, 8.00%
  6. Migraine (headache): 2 people, 8.00%
  7. Drowsiness: 2 people, 8.00%
  8. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Trintellix and Luvox?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Trintellix and Luvox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Trintellix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Luvox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Trintellix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Luvox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on vortioxetine hydrobromide and fluvoxamine maleate (the active ingredients of Trintellix and Luvox, respectively), and Trintellix and Luvox (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: